Literature DB >> 21342215

Review: The neurobiology of varicella zoster virus infection.

D Gilden1, R Mahalingam, M A Nagel, S Pugazhenthi, R J Cohrs.   

Abstract

Varicella zoster virus (VZV) is a neurotropic herpesvirus that infects nearly all humans. Primary infection usually causes chickenpox (varicella), after which virus becomes latent in cranial nerve ganglia, dorsal root ganglia and autonomic ganglia along the entire neuraxis. Although VZV cannot be isolated from human ganglia, nucleic acid hybridization and, later, polymerase chain reaction proved that VZV is latent in ganglia. Declining VZV-specific host immunity decades after primary infection allows virus to reactivate spontaneously, resulting in shingles (zoster) characterized by pain and rash restricted to one to three dermatomes. Multiple other serious neurological and ocular disorders also result from VZV reactivation. This review summarizes the current state of knowledge of the clinical and pathological complications of neurological and ocular disease produced by VZV reactivation, molecular aspects of VZV latency, VZV virology and VZV-specific immunity, the role of apoptosis in VZV-induced cell death and the development of an animal model provided by simian varicella virus infection of monkeys.
© 2011 The Authors. Neuropathology and Applied Neurobiology © 2011 British Neuropathological Society.

Entities:  

Mesh:

Year:  2011        PMID: 21342215      PMCID: PMC3176736          DOI: 10.1111/j.1365-2990.2011.01167.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  199 in total

1.  Varicella zoster virus vasculopathy and disseminated encephalomyelitis.

Authors:  Donald H Gilden
Journal:  J Neurol Sci       Date:  2002-03-30       Impact factor: 3.181

Review 2.  VZV T cell-mediated immunity.

Authors:  Adriana Weinberg; Myron J Levin
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

3.  Varicella zoster virus cerebellitis in a 66-year-old patient without herpes zoster.

Authors:  Peter Ratzka; Johannes C M Schlachetzki; Mathias Bähr; Roland Nau
Journal:  Lancet       Date:  2006-01-14       Impact factor: 79.321

4.  Clinical and pathogenetic studies of Medical Lake macaque virus infections in cynomolgus monkeys (simian varicella).

Authors:  H A Wenner; D Abel; S Barrick; P Seshumurty
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

5.  [Myelitis and optic neuritis caused by varicella].

Authors:  M A Pina; J R Ara; J L Capablo; M Omeñaca
Journal:  Rev Neurol       Date:  1997-10       Impact factor: 0.870

6.  Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens.

Authors:  J I Cohen
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

Review 7.  Pathogenesis of simian varicella virus.

Authors:  Wayne L Gray
Journal:  J Med Virol       Date:  2003       Impact factor: 2.327

8.  Characterization of the host immune response in human Ganglia after herpes zoster.

Authors:  Kavitha Gowrishankar; Megan Steain; Anthony L Cunningham; Michael Rodriguez; Peter Blumbergs; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

Review 9.  Aseptic meningitis and optic neuritis preceding varicella-zoster progressive outer retinal necrosis in a patient with AIDS.

Authors:  Carlos Franco-Paredes; Thomas Bellehemeur; Ali Merchant; Pramod Sanghi; Carlos DiazGranados; David Rimland
Journal:  AIDS       Date:  2002-05-03       Impact factor: 4.177

10.  Analytical validation of the GeXP analyzer and design of a workflow for cancer-biomarker discovery using multiplexed gene-expression profiling.

Authors:  Alex J Rai; Rashmi M Kamath; William Gerald; Martin Fleisher
Journal:  Anal Bioanal Chem       Date:  2008-10-29       Impact factor: 4.142

View more
  42 in total

1.  Shingles with secondary asymptomatic CNS involvement!

Authors:  Syed Viqar Ahmed; Hazim Hamada; Chaminda Jayawarna; Sumit Chandra
Journal:  BMJ Case Rep       Date:  2012-05-30

2.  P2X7 receptor antagonist BBG inhibits endoplasmic reticulum stress and pyroptosis to alleviate postherpetic neuralgia.

Authors:  Yuyou Zhu; Siping Zhang; Yuanbo Wu; Juan Wang
Journal:  Mol Cell Biochem       Date:  2021-05-12       Impact factor: 3.396

3.  Interaction of allergy history and antibodies to specific varicella-zoster virus proteins on glioma risk.

Authors:  Seung-Tae Lee; Paige Bracci; Mi Zhou; Terri Rice; John Wiencke; Margaret Wrensch; Joseph Wiemels
Journal:  Int J Cancer       Date:  2013-10-31       Impact factor: 7.396

4.  Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia.

Authors:  Megan Steain; Jeremy P Sutherland; Michael Rodriguez; Anthony L Cunningham; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

5.  Interferon Gamma Prolongs Survival of Varicella-Zoster Virus-Infected Human Neurons In Vitro.

Authors:  Nicholas L Baird; Jacqueline L Bowlin; Taylor J Hotz; Randall J Cohrs; Don Gilden
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

6.  Varicella zoster virus DNA does not accumulate in infected human neurons.

Authors:  Nicholas L Baird; Jacqueline L Bowlin; Xiaoli Yu; Stipan Jonjić; Jürgen Haas; Randall J Cohrs; Don Gilden
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

7.  Antiviral bioactivity of renewable polysaccharides against Varicella Zoster.

Authors:  Eiman Abu-Galiyun; Mahmoud Huleihel; Oshrat Levy-Ontman
Journal:  Cell Cycle       Date:  2019-11-14       Impact factor: 4.534

8.  Varicella-zoster virus infects human embryonic stem cell-derived neurons and neurospheres but not pluripotent embryonic stem cells or early progenitors.

Authors:  Anna Dukhovny; Anna Sloutskin; Amos Markus; Michael B Yee; Paul R Kinchington; Ronald S Goldstein
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

9.  Comprehensive analysis of varicella-zoster virus proteins using a new monoclonal antibody collection.

Authors:  Tihana Lenac Roviš; Susanne M Bailer; Venkata R Pothineni; Werner J D Ouwendijk; Hrvoje Šimić; Marina Babić; Karmela Miklić; Suzana Malić; Marieke C Verweij; Armin Baiker; Orland Gonzalez; Albrecht von Brunn; Ralf Zimmer; Klaus Früh; Georges M G M Verjans; Stipan Jonjić; Jürgen Haas
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

Review 10.  Varicella-zoster.

Authors:  Don Gilden; Maria A Nagel; Randall J Cohrs
Journal:  Handb Clin Neurol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.